Explore

Rapid Read Rapid Read
FDA Approves Freenome's Blood-Based Colorectal Cancer Screening Test for U.S. Market

FDA Approves Freenome's Blood-Based Colorectal Cancer Screening Test for U.S. Market

The U.S. Food and Drug Administration (FDA) has approved Freenome's SimpleScreen CRC, a blood-based screening test for colorectal cancer. This test, which will be commercialized by Abbott in the U.S., offers a new option for adults aged 45 and older who are at average risk for colorectal cancer. The approval follows the PREEMPT CRC study, the largest clinical validation study for a blood-based colorectal cancer screening test, involving over 48,000 participants. SimpleScreen CRC detects cancer signals from cell-free DNA in the blood, providing a non-invasive alternative to traditional colonoscopy.
Trendline Trendline
bioAffinity Technologies Introduces New Framework for Lung Cancer Detection

bioAffinity Technologies Introduces New Framework for Lung Cancer Detection

bioAffinity Technologies Introduces New Framework for Lung Cancer Detection
Trendline Trendline
Galderma Increases 2026 Sales Outlook Amid Strong First-Half Growth

Galderma Increases 2026 Sales Outlook Amid Strong First-Half Growth

Galderma Increases 2026 Sales Outlook Amid Strong First-Half Growth
Trendline Trendline
Neko Health's Full-Body Scan Gains Popularity Amid Wellness Trends

Neko Health's Full-Body Scan Gains Popularity Amid Wellness Trends

Neko Health's Full-Body Scan Gains Popularity Amid Wellness Trends
Rapid Read Rapid Read
FDA Advisory Committee Recommends Lifting Regulations on Experimental Peptides Amidst Safety Concerns

FDA Advisory Committee Recommends Lifting Regulations on Experimental Peptides Amidst Safety Concerns

A U.S. drug advisory committee has recommended that the FDA lift regulations on several experimental peptides, allowing select pharmacies to manufacture and doctors to prescribe them. This decision comes despite the lack of large-scale human trials to support the safety and efficacy of these compounds. Peptides, which are short chains of amino acids, are being marketed for a variety of health benefits, including anti-aging and injury healing. The unregulated market for these peptides is estimated to be worth between $100 million and $3 billion. The committee's recommendation aims to mitigate risks associated with purchasing these products from unregulated sources, but it also raises concerns about the message it sends regarding their safety.
Trendline Trendline
Capricor Criticizes FDA's Use of 'Obsolete' Analysis in Deramiocel Review, Stock Plummets

Capricor Criticizes FDA's Use of 'Obsolete' Analysis in Deramiocel Review, Stock Plummets

Capricor Criticizes FDA's Use of 'Obsolete' Analysis in Deramiocel Review, Stock Plummets
Rapid Read Rapid Read
U.S. Retailers Halt Mexican Produce Imports Amid Cyclospora Outbreak Concerns

U.S. Retailers Halt Mexican Produce Imports Amid Cyclospora Outbreak Concerns

Several major U.S. retailers and restaurants have ceased sourcing produce from central Mexico due to a cyclosporiasis outbreak linked to iceberg lettuce from Taylor Farms. The outbreak has resulted in 4,173 confirmed cases, with over 7,400 suspected cases, according to the U.S. Centers for Disease Control and Prevention. Former FDA Commissioner Scott Gottlieb highlighted that the outbreak might be connected to other produce like parsley and cilantro from the same region. The FDA's investigation suggests potential contamination from raw sewage due to weather conditions, though the exact cause remains under investigation. Taylor Farms has voluntarily suspended production and removed potentially affected products from the market.
Trendline Trendline
Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment

Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment

Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment
Rapid Read Rapid Read
FDA Clears AI Tool EchoNext for Early Detection of Heart Failure via ECG

FDA Clears AI Tool EchoNext for Early Detection of Heart Failure via ECG

The U.S. Food and Drug Administration has cleared EchoNext, an AI tool developed by Pathway Labs in collaboration with NewYork-Presbyterian and Columbia University Irving Medical Center, to detect structural heart disease from routine ECGs. This tool can identify six cardiac conditions, including heart failure and valve disease, which are often asymptomatic in early stages. EchoNext was trained on a large dataset of ECGs and echocardiograms and validated across multiple hospitals. It aims to bridge the gap between routine ECGs and more costly echocardiograms, offering a new layer of screening that could lead to earlier diagnosis and treatment.
Rapid Read Rapid Read
FDA Recalls Levothyroxine Sodium Tablets Due to Subpotency Concerns

FDA Recalls Levothyroxine Sodium Tablets Due to Subpotency Concerns

The Food and Drug Administration (FDA) has issued a Class II recall for certain lots of levothyroxine sodium tablets distributed by Major Pharmaceuticals. The recall is due to the tablets being 'subpotent,' meaning they may not deliver the full prescribed dose. Levothyroxine sodium is commonly used to treat underactive thyroid and goiter. The affected lots include 10-count blister packs and 100-tablet cartons with dosages ranging from 25 micrograms to 150 micrograms. The expiration dates for these lots range from July 2026 to January 2027. Patients are advised to check their medication against the FDA's list of affected lot numbers and consult their healthcare provider if there is a match. The FDA assures that any health effects from the lower dose are expected to be temporary and reversible.
Rapid Read Rapid Read
FDA Panel Supports Easier Access to Peptide Therapies Amid Safety Concerns

FDA Panel Supports Easier Access to Peptide Therapies Amid Safety Concerns

An advisory panel to the Food and Drug Administration (FDA) has recommended easing restrictions on peptide therapies, allowing specialized pharmacies in the U.S. to manufacture these compounds. Despite the FDA scientists' concerns about safety and lack of large-scale human trials, the panel voted in favor of making these experimental drugs more accessible. Peptides like BPC-157 and TB-500 are popular for their purported benefits in athletic performance and longevity. The decision comes amid a growing unregulated market where Americans are using unvetted substances sourced from overseas. Health Secretary Robert F. Kennedy Jr. has endorsed the move, emphasizing the need for a regulated market to ensure safety.
Rapid Read Rapid Read
FDA Links Salmonella Outbreak to Recalled Eggs from Texas Producer

FDA Links Salmonella Outbreak to Recalled Eggs from Texas Producer

The FDA has linked a salmonella outbreak affecting nearly 100 people in 17 states to eggs recalled by Midwest Poultry Services. The company voluntarily recalled approximately 19 million eggs produced in Texas due to potential contamination. The eggs, sold under various brand names, have sell-by dates between July 20 and August 17. The outbreak has resulted in 26 hospitalizations, though no deaths have been reported. Consumers are advised to check for recalled eggs and return them for a refund. The FDA continues to investigate other potential sources of the outbreak.